These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22752379)

  • 1. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
    van der Vorst JR; Schaafsma BE; Verbeek FP; Hutteman M; Mieog JS; Lowik CW; Liefers GJ; Frangioni JV; van de Velde CJ; Vahrmeijer AL
    Ann Surg Oncol; 2012 Dec; 19(13):4104-11. PubMed ID: 22752379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer.
    Mieog JS; Troyan SL; Hutteman M; Donohoe KJ; van der Vorst JR; Stockdale A; Liefers GJ; Choi HS; Gibbs-Strauss SL; Putter H; Gioux S; Kuppen PJ; Ashitate Y; Löwik CW; Smit VT; Oketokoun R; Ngo LH; van de Velde CJ; Frangioni JV; Vahrmeijer AL
    Ann Surg Oncol; 2011 Sep; 18(9):2483-91. PubMed ID: 21360250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer.
    Schaafsma BE; Verbeek FP; Rietbergen DD; van der Hiel B; van der Vorst JR; Liefers GJ; Frangioni JV; van de Velde CJ; van Leeuwen FW; Vahrmeijer AL
    Br J Surg; 2013 Jul; 100(8):1037-44. PubMed ID: 23696463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial.
    Valente SA; Al-Hilli Z; Radford DM; Yanda C; Tu C; Grobmyer SR
    J Am Coll Surg; 2019 Apr; 228(4):672-678. PubMed ID: 30582975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.
    Verbeek FP; Tummers QR; Rietbergen DD; Peters AA; Schaafsma BE; van de Velde CJ; Frangioni JV; van Leeuwen FW; Gaarenstroom KN; Vahrmeijer AL
    Int J Gynecol Cancer; 2015 Jul; 25(6):1086-93. PubMed ID: 25768079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients.
    Hutteman M; Mieog JS; van der Vorst JR; Liefers GJ; Putter H; Löwik CW; Frangioni JV; van de Velde CJ; Vahrmeijer AL
    Breast Cancer Res Treat; 2011 May; 127(1):163-70. PubMed ID: 21360075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
    Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
    Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients.
    Hirano A; Kamimura M; Ogura K; Kim N; Hattori A; Setoguchi Y; Okubo F; Inoue H; Miyamoto R; Kinoshita J; Fujibayashi M; Shimizu T
    Ann Surg Oncol; 2012 Dec; 19(13):4112-6. PubMed ID: 22782671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
    Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
    World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node pressure in breast cancer.
    Nathanson SD; Mahan M
    Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma.
    Gilmore DM; Khullar OV; Gioux S; Stockdale A; Frangioni JV; Colson YL; Russell SE
    Ann Surg Oncol; 2013 Jul; 20(7):2357-63. PubMed ID: 23440551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
    Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
    Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
    Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
    World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.
    Hojo T; Nagao T; Kikuyama M; Akashi S; Kinoshita T
    Breast; 2010 Jun; 19(3):210-3. PubMed ID: 20153649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
    Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
    BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green detects sentinel lymph nodes in early breast cancer.
    Liu J; Huang L; Wang N; Chen P
    J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.